PT
Pelthos Therapeutics Inc. (PTHS)
AMEX·Healthcare·Biotechnology
$23.86
+2.65%
Mkt Cap $15.45M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$54.50
Range $45.00 – $64.00
Implied Upside
+128.5%
Consensus $54.50 vs current $23.86
AMEX·Healthcare·Biotechnology
$23.86
+2.65%
Mkt Cap $15.45M
No recent rating data.
Price Target (9 analysts)
$54.50
Range $45.00 – $64.00
+128.5%
Consensus $54.50 vs current $23.86